๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Erythropoietin reduces anemia and transfusions : A randomized trial with or without erythropoietin during chemotherapy

โœ Scribed by Frank R. Dunphy; Bruce R. Harrison; Teresa L. Dunleavy; Jack J. Rodriguez; Jack G. Hilton; James H. Boyd


Book ID
101230773
Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
88 KB
Volume
86
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


BACKGROUND.

Anemia has been reported to develop during preoperative chemotherapy with paclitaxel and carboplatin. The use of recombinant human erythropoietin (EPO) has been shown to reduce anemia and subsequent packed red blood cell transfusions. The current study is a report of a Phase III, prospective, randomized trial with or without EPO that confirms the original observations of less anemia and fewer transfusions in those patients randomized to receive EPO concurrently with paclitaxel and carboplatin.


๐Ÿ“œ SIMILAR VOLUMES